nach oben

Journal of Nephrology

Erschienen in:

18.07.2022 | original Article

Echocardiographic parameters and hemodynamic instability at the initiation of continuous kidney replacement therapy

verfasst von: Panagiotis Kompotiatis, Khaled Shawwa, Jacob C. Jentzer, Brandon M. Wiley, Kianoush B. Kashani

Erschienen in: Journal of Nephrology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

Investigate the association of echocardiographic parameters with hemodynamic instability after initiating continuous kidney replacement therapy (CKRT) in a cohort of intensive care unit (ICU) patients requiring CKRT.

Methods

Historical cohort study of consecutive adults admitted to the ICU at a tertiary care hospital from December 2006 through November 2015 who underwent CKRT and had an echocardiogram done within seven days before CKRT initiation. The primary outcome was hypotension within one hour of CKRT initiation.

Results

We included 980 patients, 804 (82%) with acute kidney injury (AKI) and 176 (18%) with end-stage kidney disease (ESKD). Median patient age was 63 (± 14) years, and median Sequential Organ Failure Assessment (SOFA) score on the day of CKRT initiation was 12 (IQR 10–14). Multivariable analysis showed that Left (OR 2.01, 95% CI 1.04–3.86), and Right (OR 1.5, 95% CI 1.04–2.25) moderate and severe ventricular enlargement, Vasoactive-Inotropic Score (VIS) one hour before CKRT initiation (OR 1.18 per 10 units increase, 95% CI 1.09–1.28) and high bicarbonate fluid replacement (OR 2.52, 95% CI 1.01–6.2) were associated with hypotension after CKRT initiation.

Conclusion

Right and left ventricular enlargement are risk factors associated with hypotension after CKRT initiation.

Graphical abstract

Nur mit Berechtigung zugänglich

To maintain the rate of 3 mmol of citrate for each liter of blood (blood flow rate 200 ml/min or 1 L per 5 min), we use 300 ml/h of ACD-A, i.e., 36 mmol of citrate per hour. We have devised an estimated starting dose for the calcium chloride infusion that is titrated by the nephrologists depending on the labs (taking into consideration the absolute total and ionized calcium in addition to their ratio to monitor for citrate lock). To avoid electrolyte imbalances, we monitor labs three times a day, once starting CKRT and twice a day afterwards. We use a replacement solution with zero calcium and 22 mmol/L of bicarbonate as the standard solution.

Cerda J et al (2015) Promoting kidney function recovery in patients with AKI requiring RRT. Clin J Am Soc Nephrol 10(10):1859–1867CrossRef

Bagshaw SM et al (2005) Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 9(6):R700–R709CrossRef

Bagshaw SM et al (2008) Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 36(2):610–617CrossRef

Disease K (2012) Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138

Ronco C, Ricci Z (2008) Renal replacement therapies: physiological review. Intensive Care Med 34(12):2139–2146CrossRef

Hansrivijit P et al (2020) A meta-analysis of clinical predictors for renal recovery and overall mortality in acute kidney injury requiring continuous renal replacement therapy. J Crit Care 60(1557–8615 (Electronic)):13–22CrossRef

Bai ZH et al (2020) A nomogram to predict the 28-day mortality of critically Ill patients with acute kidney injury and treated with continuous renal replacement therapy. Am J Med Sci 36(5):607–615CrossRef

Jentzer JC et al (2020) Early noncardiovascular organ failure and mortality in the cardiac intensive care unit. Clin Cardiol 43(5):516–523CrossRef

Sasaki S et al (2001) Predictors of mortality in patients treated with continuous hemodiafiltration for acute renal failure in an intensive care setting. ASAIO J 47(1):86–91CrossRef

10.

Dos Santos TOC et al (2017) Outcomes from a cohort of patients with acute kidney injury subjected to continuous venovenous hemodiafiltration: the role of negative fluid balance. PLoS One 12(4):e0175897CrossRef

11.

Silversides JA et al (2014) Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study. Crit Care 18(6):624CrossRef

12.

Shawwa K et al (2019) Hypotension within one-hour from starting CRRT is associated with in-hospital mortality. J Crit Care 54:7–13CrossRef

13.

Reeves PB, Mc Causland FR (2018) Mechanisms, clinical implications, and treatment of intradialytic hypotension. Clin J Am Soc Nephrol 13(8):1297–1303CrossRef

14.

Augustine JJ et al (2004) A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44(6):1000–1007CrossRef

15.

Conger JD (2007) Does hemodialysis delay recovery from acute renal failure? Semin Dial 3(3):146–148CrossRef

16.

Frederic B, Shaw AD (2014) Clinical trial endpoints in acute kidney injury. Nephron Clin Pract 127(1–4):89–93

17.

Hickson LJ et al (2016) Echocardiography criteria for structural heart disease in patients with end-stage renal disease initiating hemodialysis. J Am Coll Cardiol 67(10):1173–1182CrossRef

18.

Santosh S et al (2017) Changes in pulmonary artery systolic pressure and right ventricular function in patients with end-stage renal disease on maintenance dialysis. Nephrology 24(1):74–80CrossRef

19.

Tang M et al (2018) Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis. Am J Kidney Dis 72(1):75–83CrossRef

20.

Vallabhajosyula S et al (2017) Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study. Ann Intensive Care 7(1):94CrossRef

21.

See KC et al (2017) Frequency and prognostic impact of basic critical care echocardiography abnormalities in patients with acute respiratory distress syndrome. Ann Intensive Care 7(1):120CrossRef

22.

Stamm JA et al (2011) Doppler-defined pulmonary hypertension in medical intensive care unit patients: retrospective investigation of risk factors and impact on mortality. Pulm Circ 1(1):95–102CrossRef

23.

Keleshian V et al (2019) Short, and long-term mortality among cardiac intensive care unit patients started on continuous renal replacement therapy. J Crit Care 55:64–72CrossRef

24.

Ferrada P et al (2014) Findings of a randomized controlled trial using limited transthoracic echocardiogram (LTTE) as a hemodynamic monitoring tool in the trauma bay. J Trauma Acute Care Surg 76(1):31CrossRef

25.

Blum M, Ferrada P (2017) Ultrasound and other innovations for fluid management in the ICU. Surg Clin North Am 97(6):1323–1337CrossRef

26.

Ferrada P et al (2013) A, B, C, D, echo: limited transthoracic echocardiogram is a useful tool to guide therapy for hypotension in the trauma bay—a pilot study. J Trauma Acute Care Surg 74(1):220–223CrossRef

27.

Rostoker G et al (2009) Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension. Cardiology 114(2):142–149CrossRef

28.

Duman D et al (2008) Dialysis-induced hypotension is associated with impaired aortic elasticity in patients undergoing chronic hemodialysis. Blood Press Monit 13(2):73–78CrossRef

29.

Alsara A et al (2011) Derivation and validation of automated electronic search strategies to identify pertinent risk factors for postoperative acute lung injury. Mayo Clin Proc 86(5):382–388CrossRef

30.

Herasevich V et al (2010) Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc 85(3):247–254CrossRef

31.

Singh B et al (2012) Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records. Mayo Clin Proc 87(9):817–824CrossRef

32.

Jentzer JC et al (2020) Temporal trends and clinical outcomes associated with vasopressor and inotrope use in the cardiac intensive care unit. Shock 53(4):452–459CrossRef

33.

Kompotiatis P et al (2019) Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy. PLoS One 14(1):e0209994CrossRef

34.

Nagueh SF et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22(2):107–133CrossRef

35.

Rudski LG et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685–713 (quiz 786-8)CrossRef

36.

Zoghbi WA et al (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16(7):777–802CrossRef

37.

Baumgartner H et al (2009) Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 22(1):1–23 (quiz 101–2)CrossRef

38.

Felker GM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342(15):1077–1084CrossRef

39.

Martin L et al (2019) The septic heart: current understanding of molecular mechanisms and clinical implications. Chest 155(2):427–437CrossRef

40.

Shawwa K et al (2021) Change in right ventricular systolic function after continuous renal replacement therapy initiation and renal recovery. J Crit Care 62:82–87CrossRef

41.

Tehranian S, Shawwa K, Kashani KB (2021) Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy. Clin Kidney J 14(2):564–569CrossRef

42.

Schaubroeck HA et al (2020) Acute cardiorenal syndrome in acute heart failure: focus on renal replacement therapy. Eur Heart J Acute Cardiovasc Care 9(7):802–811CrossRef

43.

Kashani K et al (2017) Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: a propensity-matched cohort study. PLoS One 12(9):e0185064CrossRef

44.

Pichette C et al (1982) Elevation of the blood lactate concentration by alkali therapy without requiring additional lactic acid accumulation. Crit Care Med 10(5):323–326CrossRef

Titel: Echocardiographic parameters and hemodynamic instability at the initiation of continuous kidney replacement therapy
verfasst von: Panagiotis Kompotiatis
Khaled Shawwa
Jacob C. Jentzer
Brandon M. Wiley
Kianoush B. Kashani
Publikationsdatum: 18.07.2022
Verlag: Springer International Publishing
Erschienen in: Journal of Nephrology / Ausgabe 1/2023
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-022-01400-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis

Renal sarcoidosis

Association of dietary proteins with serum creatinine and estimated glomerular filtration rate in a general population sample: the CHRIS study

Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease

Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients